✨ 6 results found - Searched 21740 records in 3ms.
Tesis
Proporsi ekspresi programmed death ligand-1 (PD-L1) pada neoplasma neuroendokrin paru di Rumah Sakit Umum Pusat Persahabatan
2023 | BY Andika Chandra Putra - Sita Laksmi Andarini - Romi Beginta - Gigih Setiawan- The proportion of programmed death ligand-1 (PD-L1) expression in lung neuroendocrine neoplasms at Persahabatan General Hospital.
- Nomor Panggil T23581fk
Tesis
Proporsi gambaran penyakit paru interstisial pada pasien kanker paru karsinoma bukan sel kecil dengan terapi epidermal growth factor receptor tyrosine kinase inhibitor di RSUP Persahabatan
2023 | BY Marscha Iradyta Ais - Sita Laksmi Andarini - Dianiati Kusumo Sutoyo - Maryastuti- The proportion of interstial lung disease features in patients with non small cell lung cancer treated with epidermal growth factor receptors tyrosine kinase inhibitor at Persahabatan Hospital.
- Nomor Panggil T23187fk
Tesis
Prevalens Penyakit Paru Obstruksi Kronik (PPOK) dan Emfisema Berdasarkan Pemeriksaan Spirometri dan Computed Tomography Scanning (CT-scan) Toraks Pada Pasien Kanker Paru di Rumah Sakit Umum Pusat Persahabatan
2019 | BY Prima Belia Fathana - Faisal Yunus - Sita Laksmi Andarini - Aziza G. Icksan- Prevalence of Chronic Obstructive Pulmonary Disease and Emphysema Based on Spirometry and Thorax CT-scan among Lung Cancer Patients Treated at Persahabatan Hospital Jakarta, Indonesia.
- Nomor Panggil T19279fk
Tesis
Efikasi dan Toksisiti Erlotinib/Gefitinib sebagai Terapi Lini Kedua Pada Pasien Kanker Paru Jenis Karsinoma Bukan Sel Kecil
2015 | BY Sita Laksmi Andarini - Jamaluddin M. - Achmad Hudoyo- Efficacy and Toxicity Erlotinib/Gefitinib as Second Line Therapy in Non-Small Cell Lung Cancer Patients.
- Nomor Panggil T 15 543 FK
Tesis
Analisis Waktu Tunggu dan Biaya Penegakan Diagnosis Kanker Paru Di RSUP Persahabatan - Diagnostic Time And Cost Of Lung Cancer In Persahabatan Hospital.
2017 | BY Inggar Pertiwi - Elisna Syahruddin - Sita Laksmi Andarini- Nomor Panggil T16527fk
Tesis
Peran quiescent lung cancer stem cell (CSC) dalam proses resistans terhadap agen epidermal growth factor receptortyrosine kinase inhibitor (EGFR-TKI) pada adenokarsinoma paru dengan mutasi EGFR positif
2020 | BY Moulid Hidayat - Sita Laksmi Andarini - Fumiyuki Takahashi- Role of quiescent lung cancer stem cells in epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR- TKI) resistance in EGFR-mutant lung adenocarcinoma.
- Nomor Panggil T20481fk